Description

Oxymetholone 50 mg

Marque : Magnus Pharmaceuticals
Contenu : 50 tablets | 50 mg per tablet
Prix : €49
Fabriqué en : L'Europe

🧪 Product Overview

Oxymetholone 50 mg provides one of the most potent oral anabolic agents available for research. Originally commercialized as Anadrol-50 for anemia treatment, it is now widely studied for hypertrophy models, nitrogen-balance enhancement, glycogen modulation, and erythropoiesis.

Its di-methyl structure and 2-hydroxymethylene group contribute to near-100% oral bioavailability and a high anabolic-to-androgenic ratio. These same structural features, however, result in significant hepatotoxic risk. A short ~8-hour half-life supports twice-daily dosing, while long-lived urinary metabolites enable detection beyond 10 days.

✅ Key Research Highlights

Explosive anabolic potency: AR-binding assays show 2–4× testosterone activity, producing rapid muscle gain
Erythropoiesis support: Clinically effective in increasing red-cell mass for anemia protocols
Nitrogen & glycogen regulation: Enhances carbohydrate use and improves nitrogen retention in catabolic models
Oral PK: ~8-hour half-life with 1–2 h C<sub>max</sub> peak; ideal for split-dose trials
Anti-doping relevance: Long-term urinary metabolites yield extended detection via LC-MS/MS
WADA status: Fully banned under S1 category — exposure results in doping violation

🔬 Suggested Laboratory Applications

Acute hypertrophy & strength-gain simulations
Nitrogen balance and glycogen metabolism modeling
Erythropoietic support in anemia-related studies
Hepatotoxicity evaluation in DILI-sensitive trials
Anti-doping method validation and exposure tracking

📊 Technical Specifications

Champ d'application	Données
Nom chimique	Oxymetholone
Formule chimique	C<sub>21</sub>H<sub>32</sub>O<sub>3</sub>
Synonymes	Anadrol-50, Anapolon, 2-Hydroxymethylene-17α-methyl-5α-androstan-17β-ol-3-one
Poids moléculaire	332.48 g/mol
Numéro CAS	434-07-1
Demi-vie	~8 hours (oral), peak in 1–2 h
Fenêtre de détection	≥ 10 days via urinary 17-epi metabolites
Avantages documentés	↑ Lean mass, ↑ strength, ↑ erythropoiesis
Principaux risques	Cholestasis, hepatotoxicity, HDL↓/LDL↑, hypertension, virilisation
Composé actif total	2,500 mg per carton (50 mg × 50 tablets)
Durée de conservation	36 months (manufacturer specification)

⚙️ PubChem-Supported Research Insights

Rapid lean-mass gain documented in 6-week protocols
Powerful erythropoietic effects in clinical anemia cases
Supports carbohydrate utilization and glycogen sparing
Produces strong nitrogen balance even in catabolic states
Extended detection window critical for anti-doping tests

⚠️ Documented Research Side Effects

Severe liver stress and cholestasis at moderate doses
Notable dyslipidemia (HDL↓, LDL↑), water retention
Androgenic side effects include mood shifts and virilisation
Hypertension and cardiovascular strain at high exposure levels

🧯 Handling & Compliance

Réservé à la recherche — Not for human or veterinary use
Store between 15–25°C, protect from moisture and light
Purchase confirms qualified researcher status
Handle in compliance with SDS and lab protocols